IP Verse

Combination Therapy Using Liposomal Irinotecan And A Parp Inhibitor For Cancer Treatment - EP3337467

PATENT ANALYSIS

Patent Details

Grant Date
Dec 9, 2020
Company
IPSEN BIOPHARM LTD.
Oppositions

SANDOZ AG

More patents of Ipsen Biopharm Ltd.

EP3266456

EP3337467

EP3337478

Want to monitor this patent?

Feel free to send us a message here and we will get back to you